EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation

Bohan Zhang, Lianghui Dong, Junshun Gao, Luoxi Yuan, Weixin Wang, Zhuxian Zhou, Nan Wang, Zhe-Sheng Chen

Integrated Diagnostics · 2026-12 · 1 (1) · 100003

DOI: 10.1016/j.intdia.2026.100003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrated Diagnostics, 2026-12. Verfasst von Bohan Zhang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, B., Dong, L., Gao, J., Yuan, L., Wang, W., Zhou, Z., Wang, N., & Chen, Z. (2026). Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation. Integrated Diagnostics, 1(1), 100003. https://doi.org/10.1016/j.intdia.2026.100003

Vancouver

Zhang B, Dong L, Gao J, Yuan L, Wang W, Zhou Z, et al. Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation. Integrated Diagnostics. 2026;1(1):100003. doi:10.1016/j.intdia.2026.100003

BibTeX
@article{Zhang2026,
  author = {Zhang, Bohan and Dong, Lianghui and Gao, Junshun and Yuan, Luoxi and Wang, Weixin and Zhou, Zhuxian and Wang, Nan and Chen, Zhe-Sheng},
  title = {Unleashing the power of omics-driven liquid biopsy in anti-cancer drug resistance: From biomarker discovery to clinical translation},
  journal = {Integrated Diagnostics},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {100003},
  doi = {10.1016/j.intdia.2026.100003}
}
Kostenlos starten →